Docetaxel response in BRCA1,p53-deficient mammary tumor cells is affected by Huntingtin and BAP1

Proceedings of the National Academy of Sciences, Volume 121, Issue 52, December 2024. <br/>SignificanceChemotherapy with taxanes, essential in treating various cancers, including TNBC, often faces challenges due to unpredictable patient responses and the emergence of secondary resistance. This unpredictability is exacerbated by intra- and …



Source link